Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Regulates Atherosclerosis Through C-C Motif Chemokine Ligand 2-Mediated Monocyte Infiltration.

Autor: Xiang Yi Kong, Huse, Camilla, Kuan Yang, Øgaard, Jonas, Berges, Natalia, Vik, Erik Sebastian, Nawaz, Meh Sameen, Quiles-Jiménez, Ana, Abbas, Azhar, Gregersen, Ida, Holm, Sverre, Bjerkli, Vigdis, Rashidi, Azita, Fladeby, Cathrine, Suganthan, Rajikala, Sagen, Ellen Lund, Skjelland, Mona, Lång, Anna, Bøe, Stig Ove, Bjørås, Magnar

Publikováno v: Journal of the American Heart Association; 7/20/2021, Vol. 10 Issue 14, following p1-14, 20p

Deletion of Endonuclease V suppresses chemically induced hepatocellular carcinoma.

Autor: Kong XY; Research Institute of Internal Medicine, Oslo University Hospital HF, Rikshospitalet, NO-0424 Oslo, Norway., Vik ES; Department of Microbiology, Oslo University Hospital HF, Rikshospitalet and University of Oslo, NO-0424 Oslo, Norway., Nawaz MS; Department of Microbiology, Oslo University Hospital HF, Rikshospitalet and University of Oslo, NO-0424 Oslo, Norway., Berges N; Department of Microbiology, Oslo University Hospital HF, Rikshospitalet and University of Oslo, NO-0424 Oslo, Norway., Dahl TB; Research Institute of Internal Medicine, Oslo University Hospital HF, Rikshospitalet, NO-0424 Oslo, Norway.; Department of Microbiology, Oslo University Hospital HF, Rikshospitalet and University of Oslo, NO-0424 Oslo, Norway., Vågbø C; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, NO-7491 Trondheim, Norway., Suganthan R; Department of Microbiology, Oslo University Hospital HF, Rikshospitalet and University of Oslo, NO-0424 Oslo, Norway., Segers F; Research Institute of Internal Medicine, Oslo University Hospital HF, Rikshospitalet, NO-0424 Oslo, Norway., Holm S; Research Institute of Internal Medicine, Oslo University Hospital HF, Rikshospitalet, NO-0424 Oslo, Norway., Quiles-Jiménez A; Research Institute of Internal Medicine, Oslo University Hospital HF, Rikshospitalet, NO-0424 Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, NO-0317 Oslo, Norway., Gregersen I; Research Institute of Internal Medicine, Oslo University Hospital HF, Rikshospitalet, NO-0424 Oslo, Norway., Fladeby C; Department of Microbiology, Oslo University Hospital HF, Rikshospitalet and University of Oslo, NO-0424 Oslo, Norway., Aukrust P; Research Institute of Internal Medicine, Oslo University Hospital HF, Rikshospitalet, NO-0424 Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, NO-0317 Oslo, Norway.; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Rikshospitalet, NO-0424 Oslo, Norway., Bjørås M; Department of Microbiology, Oslo University Hospital HF, Rikshospitalet and University of Oslo, NO-0424 Oslo, Norway.; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, NO-7491 Trondheim, Norway., Klungland A; Department of Microbiology, Oslo University Hospital HF, Rikshospitalet and University of Oslo, NO-0424 Oslo, Norway.; Department of Molecular Medicine, Institute of Basic Medical Sciences, University ofOslo, NO-0317 Oslo, Norway., Halvorsen B; Research Institute of Internal Medicine, Oslo University Hospital HF, Rikshospitalet, NO-0424 Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, NO-0317 Oslo, Norway., Alseth I; Department of Microbiology, Oslo University Hospital HF, Rikshospitalet and University of Oslo, NO-0424 Oslo, Norway.

Publikováno v: Nucleic acids research [Nucleic Acids Res] 2020 May 07; Vol. 48 (8), pp. 4463-4479.